KATHLEEN BOLGER: Open Payments
NPI 1497772966 · FRANKLIN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,246 in 53 payments from 13 companies in 2025. Trend: 2023 $1,534 · 2024 $1,369 · 2025 $1,246
Food & beverage: $1,246
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $316 |
| Alkermes, Inc. | 8 | $200 |
| Otsuka America Pharmaceutical, Inc. | 8 | $167 |
| Janssen Pharmaceuticals, Inc | 5 | $144 |
| E.R. Squibb & Sons, L.L.C. | 5 | $97 |
| Teva Pharmaceuticals USA, Inc. | 4 | $72 |
| Axsome Therapeutics, Inc. | 3 | $70 |
| ABBVIE INC. | 2 | $54 |
| Lundbeck LLC | 2 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
Products named: CAPLYTA, REXULTI, ARISTADA, INVEGA SUSTENNA, COBENFY, Auvelity, AUSTEDO XR, VRAYLAR.
Industry payments across NY — which companies pay providers there.
